RZLT is a biotechnology company which has products in clinical development. Many are aware that means rigorous clinical trials before an FDA approval and a product line that generates earnings. Stock price is more about growth and potential more than anything else. That said the chart looks good and I sense there is momentum heading into earnings in the next...
FGEN has been uptrending for two weeks. In November's earnings it beat on revenue and burned less cash than projected. Another earnings report is impending. On the 30 minute chart, price has pumped 250%. The volume is okay but is not showing a rise and the price volume trend is flat. This is an unusual pattern. The mass index indicator shows hints of ...
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with...
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with...
There is some great news in regards to a recent announcement about FibroGenesis (FGEN)'s pre-clinical trial using fibroblast cell therapy.